Movers

Why Is Scholar Rock Holding Stock Climbing Today?

Posted on: Friday, November 14, 2025 - 1:49pm

Man holding financial chart in hand that is moving upwards with arrow moving up

Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.

All terms: Biotech, Equities, News, Health Care, Top Stories, Markets, Movers, General

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing

Posted on: Friday, November 14, 2025 - 1:35pm

Smartphone displaying "hims | hers" on keyboard.

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

All terms: Large Cap, News, Health Care, Movers, Trading Ideas, Insurance, General

Why Is Sigma Lithium Stock Gaining Friday?

Posted on: Friday, November 14, 2025 - 1:23pm

Lithium element symbol from the periodic table near metallic lithium.

Sigma Lithium posts Q3 revenue of $28.5M, EPS loss narrows to 10 cents, as sales volumes rise 21% and lithium prices jump 33% Q/Q.

All terms: Earnings, Equities, News, Guidance, Small Cap, Top Stories, Movers

What's Going On With Under Armour Shares Friday?

Posted on: Friday, November 14, 2025 - 1:21pm

Under Armour sig attached to side of stone building

Under Armour shares are under pressure amid restructuring expansion and brand separation agreement with Steph Curry.

All terms: News, Movers

Shkreli's Shorts Up 600% As Quantum Stocks Tank

Posted on: Friday, November 14, 2025 - 1:06pm

Business photo shows the sale of an asset or stock that the seller does not own

Martin Shkreli celebrates 600% gains on his quantum stock short bets.

All terms: Mid Cap, News, Short Sellers, Movers, Tech, Trading Ideas

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

Posted on: Friday, November 14, 2025 - 1:02pm

Scientist with pipette and futuristic digital interface

Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.

All terms: Biotech, News, Health Care, Top Stories, Movers, General

Walmart's CEO Shake-Up Catches Analysts And Investors Off Guard

Posted on: Friday, November 14, 2025 - 1:01pm

Walmart van parked in front of Walmart store, Manassas, Virginia

Walmart shares dipped after the retailer's unexpectedly timed CEO transition drew surprise from analysts amid a shaky consumer backdrop.

All terms: Equities, News, Markets, Analyst Ratings, Movers, Trading Ideas, General

Kura Scores A Big Win As FDA Approves Its New Leukemia Pill

Posted on: Friday, November 14, 2025 - 12:43pm

Komzifti wins full FDA approval for NPM1-mutated AML, supported by KOMET-001 data, as Wedbush boosts Kura Oncology's price target to $38.

All terms: Biotech, News, Health Care, FDA, Top Stories, Movers, General

Bearish On AI? Tell That To The $600 Billion Big Tech Is About To Spend

Posted on: Friday, November 14, 2025 - 12:29pm

AI tech pullback in major names like Tesla, Microsoft, Palantir, and Nvidia reflects a temporary panic rather than a fundamental shift.

All terms: Analyst Color, News, Top Stories, Analyst Ratings, Movers, Tech, Trading Ideas

Sempra Analyst Turns Bullish On Increased Focus On Texas

Posted on: Friday, November 14, 2025 - 12:28pm

Goldman Sachs upgrades Sempra (SRE) to Buy, citing focus on Texas and potential for earnings growth from data centers, infrastructure and population growth.

All terms: Analyst Color, Upgrades, Price Target, Analyst Ratings, Movers, Trading Ideas